JP2000514035A - リポソーム調製物の製造方法 - Google Patents

リポソーム調製物の製造方法

Info

Publication number
JP2000514035A
JP2000514035A JP09501158A JP50115897A JP2000514035A JP 2000514035 A JP2000514035 A JP 2000514035A JP 09501158 A JP09501158 A JP 09501158A JP 50115897 A JP50115897 A JP 50115897A JP 2000514035 A JP2000514035 A JP 2000514035A
Authority
JP
Japan
Prior art keywords
fractions
liposome
lipid
formulation
liposome formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP09501158A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000514035A5 (cg-RX-API-DMAC7.html
Inventor
カール エル． アルビング
ロベルタ アール． オウェンズ
ナビラ エム． ワッセフ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United States Department of the Army
Original Assignee
United States Department of the Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23888222&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2000514035(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by United States Department of the Army filed Critical United States Department of the Army
Publication of JP2000514035A publication Critical patent/JP2000514035A/ja
Publication of JP2000514035A5 publication Critical patent/JP2000514035A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
JP09501158A 1995-06-07 1996-06-06 リポソーム調製物の製造方法 Ceased JP2000514035A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/475,581 US6007838A (en) 1995-06-07 1995-06-07 Process for making liposome preparation
US08/475,581 1995-06-07
PCT/US1996/008622 WO1996040063A1 (en) 1995-06-07 1996-06-06 Process for making liposome preparation

Publications (2)

Publication Number Publication Date
JP2000514035A true JP2000514035A (ja) 2000-10-24
JP2000514035A5 JP2000514035A5 (cg-RX-API-DMAC7.html) 2004-07-08

Family

ID=23888222

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09501158A Ceased JP2000514035A (ja) 1995-06-07 1996-06-06 リポソーム調製物の製造方法

Country Status (12)

Country Link
US (1) US6007838A (cg-RX-API-DMAC7.html)
EP (1) EP0831779B2 (cg-RX-API-DMAC7.html)
JP (1) JP2000514035A (cg-RX-API-DMAC7.html)
AT (1) ATE203898T1 (cg-RX-API-DMAC7.html)
AU (1) AU699055B2 (cg-RX-API-DMAC7.html)
CA (1) CA2223808A1 (cg-RX-API-DMAC7.html)
DE (1) DE69614385T3 (cg-RX-API-DMAC7.html)
DK (1) DK0831779T4 (cg-RX-API-DMAC7.html)
ES (1) ES2159358T3 (cg-RX-API-DMAC7.html)
IL (1) IL122486A (cg-RX-API-DMAC7.html)
PT (1) PT831779E (cg-RX-API-DMAC7.html)
WO (1) WO1996040063A1 (cg-RX-API-DMAC7.html)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU752802C (en) * 1997-11-14 2006-04-13 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
US7115297B2 (en) 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
DE60130440D1 (de) 2000-03-21 2007-10-25 Suzanne Jaffe Stillman Aufgussbeutel mit dekorativen gebrauchsmitteln, trägerelementen, abgabevorrichtung und verfahren
US8642051B2 (en) 2000-03-21 2014-02-04 Suzanne Jaffe Stillman Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s)
US20040022838A1 (en) * 2001-06-20 2004-02-05 Holick Michael F. Regulation of cell proliferation and differentiation using topically applied peptides
US6852323B2 (en) 2000-07-21 2005-02-08 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
US7223406B2 (en) * 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
US20040082521A1 (en) * 2002-03-29 2004-04-29 Azaya Therapeutics Inc. Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
EP1519714B1 (en) 2002-06-28 2010-10-20 Protiva Biotherapeutics Inc. Method and apparatus for producing liposomes
CN1674933B (zh) 2002-08-02 2012-09-26 葛兰素史密丝克莱恩生物有限公司 疫苗组合物
JP2006508126A (ja) * 2002-11-06 2006-03-09 アザヤ セラピューティクス インコーポレイティッド 薬学的製剤のタンパク質安定化されたリポソーム製剤
JP5639338B2 (ja) 2005-07-27 2014-12-10 プロチバ バイオセラピューティクス インコーポレイティッド リポソームの製造システムおよび製造方法
WO2007049279A2 (en) * 2005-10-26 2007-05-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem A liposomal combination and uses thereof
ES2337309T5 (es) 2006-06-12 2013-07-30 Glaxosmithkline Biologicals S.A. Vacuna
NO329127B1 (no) * 2006-09-12 2010-08-30 Epitarget As Sporbart partikulaert materiale for legemiddelavlevering omfattende et matriseeller membranmateriale, et legemiddel, og et T1- og et T2*- magnetisk resonanskontrastmiddel
EP2427243A4 (en) 2009-05-05 2012-11-21 Vapogenix Inc NEW FORMULATIONS OF VOLATILE ANESTHETICS AND METHOD OF ADMINISTRATION
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
ES2667425T3 (es) 2011-06-10 2018-05-10 Oregon Health & Science University Glucoproteínas y vectores recombinantes de CMV
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
PL2968214T3 (pl) 2013-03-15 2021-11-02 Newvapogen, Inc. Nowe kompozycje przeciwbólowe
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US9392814B2 (en) 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package
PL3615005T3 (pl) 2017-04-28 2025-10-06 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Kompozycje i sposoby dostarczania szczepionki
CN114126600B (zh) * 2020-01-20 2024-03-08 广州谷森制药有限公司 三苯乙酸维兰特罗的脂质体制剂
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12285419B2 (en) 2021-10-14 2025-04-29 Pacira Pharmaceuticals, Inc. Bupivacaine multivesicular liposome formulations and uses thereof
US12280149B1 (en) 2024-05-20 2025-04-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12156940B1 (en) 2024-05-20 2024-12-03 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408387A2 (fr) † 1975-06-30 1979-06-08 Oreal Compositions a base de dispersions aqueuses de spherules lipidiques
AU7128887A (en) * 1986-02-10 1987-08-25 Liposome Technology, Inc. Controlled-release liposome delivery system
US4752425A (en) † 1986-09-18 1988-06-21 Liposome Technology, Inc. High-encapsulation liposome processing method
DE4124252A1 (de) * 1991-07-22 1993-01-28 Knoll Ag Verfahren zur herstellung einer sterilfiltrierbaren wirkstoffloesung
US5631237A (en) † 1992-12-22 1997-05-20 Dzau; Victor J. Method for producing in vivo delivery of therapeutic agents via liposomes
FR2714601B1 (fr) † 1993-12-30 1996-02-09 Oreal Composition dépigmentante pour le traitement simultané des couches superficielles et profondes, son utilisation.

Also Published As

Publication number Publication date
EP0831779B2 (en) 2005-01-19
EP0831779A1 (en) 1998-04-01
AU699055B2 (en) 1998-11-19
WO1996040063A1 (en) 1996-12-19
IL122486A0 (en) 1998-06-15
PT831779E (pt) 2001-11-30
EP0831779B1 (en) 2001-08-08
ES2159358T3 (es) 2001-10-01
CA2223808A1 (en) 1996-12-19
DE69614385T2 (de) 2002-05-23
IL122486A (en) 2000-07-16
AU6036596A (en) 1996-12-30
DE69614385T3 (de) 2005-05-25
DK0831779T3 (da) 2001-10-08
US6007838A (en) 1999-12-28
DK0831779T4 (da) 2005-06-06
ATE203898T1 (de) 2001-08-15
DE69614385D1 (de) 2001-09-13

Similar Documents

Publication Publication Date Title
AU699055B2 (en) Process for making liposome preparation
RU2216315C2 (ru) Способ получения липосом
EP0537326A1 (fr) Vecteur de delivrance d'arn
JPH0551338B2 (cg-RX-API-DMAC7.html)
JPH06510024A (ja) 医薬調合品及び方法
CN114469953B (zh) 一种具有协同作用的抗肿瘤药物组合物、纳米制剂及其制备方法和应用
JPH06508777A (ja) 骨形成性蛋白医薬処方物
CN1044093C (zh) 低毒性药物类脂制剂
JPH08507077A (ja) ワクチン送達系、および活性成分の遠隔封入のための保存安定性前駆溶液
CN110464835B (zh) 一种胰岛素柔性微粒及其制剂
JP6738500B2 (ja) 水難溶性薬物が内封されたタンパク質粒子およびその調製方法
JP2020519241A (ja) 膜脂質被覆されたナノ粒子および使用方法
CN1055483A (zh) 肽药物的长效脂质体制剂及其制备
CN101391098B (zh) 一种蜂毒素脂质体制剂及其制备方法
JPS62155223A (ja) 局所的投与により術後の癒着形成を抑制するための組成物
CN1479609A (zh) 肽的经口递送
JP2003514832A (ja) 微粒子製造に関する連続フロー法
JP2005529086A (ja) 精製大豆ホスファチジルセリンによって作製される渦巻状物
CN114306626A (zh) 一种阿伦膦酸修饰的黄芪甲苷mPEG-PLGA纳米胶束及其抗骨质疏松作用研究
TWI388344B (zh) 儲存奈米微粒調合物之方法
CN113967262A (zh) 一种骨层级靶向-超声触发式药物递送系统、制备方法及应用
US20250195437A1 (en) Continuous spin freeze-drying of nucleic acid containing compositions
CN111265497B (zh) 口腔载药贴膜及其制备方法、口腔载药贴膜组件及其制备方法
JPH09501168A (ja) 生物構造体、生体ポリマー及び／又はオリゴマーを充填した小胞の調製方法
CN102406610A (zh) 一种具有长循环性能的微粒给药系统及其制备方法

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070508

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20070806

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20070914

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20070905

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20071015

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20071004

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20071119

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071107

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080507

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20080526

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20080804

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20080912

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20081229

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090421